Pentasa tablets approved for once daily use

Pentasa (mesalazine) 500mg slow-release tablets have been licensed for once daily administration in the maintenance therapy of mild to moderate ulcerative colitis.

All oral formulations of Pentasa are now approved for once daily dosing in a maintenance setting.

View Pentasa drug record

Further information: Ferring

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Metformin use during pregnancy linked to reduced gestational weight gain

Metformin use during pregnancy linked to reduced gestational weight gain

Exposure to metformin versus other treatments during...

Drug price changes - live tracker

Drug price changes - live tracker

EXCLUSIVE TO SUBSCRIBERS Use our constantly updated...